Evidence map›Paper›PMID 33559793›Full record

Review3D printing in medicine2021

Applications of 3D printing in breast cancer management.

Arpine Galstyan, Michael J Bunker, Fluvio Lobo, Robert Sims, James Inziello, Jack Stubbs, Rita Mukhtar, Tatiana Kelil

Erratum issuedAbstract readReview
In one paragraph

Review in 3D printing in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Arpine GalstyanUniversity of California, 1600 Divisadero St, C250, Box 1667, San Francisco, CA, 94115, USA.
Michael J BunkerUniversity of California, 1600 Divisadero St, C250, Box 1667, San Francisco, CA, 94115, USA.
Fluvio LoboUniversity of Florida, 3100 Technology Pkwy, Orlando, FL, 32826, USA.
Robert SimsUniversity of Florida, 3100 Technology Pkwy, Orlando, FL, 32826, USA.
James InzielloUniversity of Florida, 3100 Technology Pkwy, Orlando, FL, 32826, USA.
Jack StubbsUniversity of Florida, 3100 Technology Pkwy, Orlando, FL, 32826, USA.
Rita MukhtarUniversity of California, 1600 Divisadero St, C250, Box 1667, San Francisco, CA, 94115, USA.
Tatiana KelilUniversity of California, 1600 Divisadero St, C250, Box 1667, San Francisco, CA, 94115, USA. Tatiana.kelil@ucsf.edu.ORCID http://orcid.org/0000-0003-4718-3839

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three-dimensional (3D) printing is a method by which two-dimensional (2D) virtual data is converted to 3D objects by depositing various raw materials into successive layers. Even though the technology was invented almost 40 years ago, a rapid expansion in medical applications of 3D printing has only been observed in the last few years. 3D printing has been applied in almost every subspecialty of medicine for pre-surgical planning, production of patient-specific surgical devices, simulation, and training. While there are multiple review articles describing utilization of 3D printing in various disciplines, there is paucity of literature addressing applications of 3D printing in breast cancer management. Herein, we review the current applications of 3D printing in breast cancer management and discuss the potential impact on future practices.

Identifiers

PMID33559793
PMCPMC7871648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.